Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001628280-25-010115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-03-01 | AMRX | Konidaris Tasos | EVP, CFO | M - OptEx | — | +36.2K | 563.5K | +7% | — |
| D | 2025-03-04 | 2025-03-01 | AMRX | Konidaris Tasos | EVP, CFO | F - Tax | $8.67 | -13.5K | 550.0K | -2% | -$117.0K |
| D | 2025-03-04 | 2025-03-01 | AMRX | Konidaris Tasos | EVP, CFO | M - OptEx | $0.00 | -36.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-01 | M | A | 36,197 | — | 563,513 | D | — | — | (F1) Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 2 | Common | Class A Common Stock | 2025-03-01 | F | D | 13,494 | $8.67 | 550,019 | D | — | — | (F3) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-03-01 | M | D | 36,197 | $0.00 | 0 | D | — · — to — | 36,197 Class A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) On March 1, 2021, the reporting person was granted 144,788 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. |